WS #13445

06:23→06:52 UTC
From 498 msgs · 5 key-dev

Novo Nordisk raised guidance but analysts unimpressed, with oral Wegovy and CagriSema results mixed, intensifying competition with Eli Lilly.

Novo Nordisk guidance and competition

Novo Nordisk raised guidance but analysts unimpressed, with oral Wegovy and CagriSema results mixed, intensifying competition with Eli Lilly.

Full world state #13445 →

US-Iran Hormuz deal progressSpaceX earnings and AI capexRBI policy decision
← WS #13444WS #13446 →
BearishNegativeNeutralPositiveBullish|ORDER: SIZE ▾↻ RESHUFFLE▸ LATER / NOW|